Related Experiment Video
Updated: Jun 19, 2026
07:17
An Orthotopic Resectional Mouse Model of Pancreatic Cancer
Published on: September 24, 2020
Parenchyma-sparing resections for pancreatic neoplasms
Stefano Crippa1, Letizia Boninsegna, Stefano Partelli
1Department of Surgery, Chirurgia Generale B, Policlinico GB Rossi, University of Verona, Piazzale LA Scuro 10, 37134, Verona, Italy.
Journal of Hepato-Biliary-Pancreatic Sciences
|October 30, 2009
Summary
Parenchyma-sparing pancreatic resections offer safe and effective treatment for benign or low-grade malignant tumors. These procedures provide good long-term functional and oncological outcomes, especially in young patients requiring pancreatic surgery.
Area of Science:
- Surgical Oncology
- Gastroenterology
- Pancreatic Surgery
Background:
- Increasing indications for pancreatic resection of benign/low-grade malignant lesions.
- Focus on young patients with long life expectancy.
- Need to mitigate exocrine/endocrine insufficiency risks.
Purpose of the Study:
- Evaluate parenchyma-sparing pancreatic resections.
- Analyze outcomes of enucleation, middle pancreatectomy, and middle-preserving pancreatectomy.
- Assess functional and oncological results.
Main Methods:
- Comprehensive literature review.
- Inclusion of authors' surgical experience.
- Analysis of short- and long-term patient outcomes.
Main Results:
- Parenchyma-sparing resections are feasible.
- Postoperative morbidity is significant but manageable.
- Good long-term functional and oncological results observed.
Conclusions:
- Parenchyma-sparing resections are safe and effective for selected pancreatic neoplasms.
- These techniques yield favorable long-term outcomes.
- Laparoscopic enucleation is recommended when feasible.
